Stay updated on IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A banner announces NIH website changes and says the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.5%
    Check dated 2026-10-25T14:43:31.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer’s software revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T15:13:15.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The website footer revision identifier changed from v3.7.0 to v3.7.1, while the study record history remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-11T14:57:59.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study record history, and the previous entry v3.6.6 was removed. This updates the page’s revision history to reflect the latest version of the record.
    Difference
    0.1%
    Check dated 2026-09-20T19:43:55.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The record history now lists a new latest revision: v3.6.6, replacing v3.6.5. This indicates a minor update to the study record history.
    Difference
    0.1%
    Check dated 2026-08-30T17:30:44.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5 on the page. This reflects a maintenance update to the record history rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-08-09T07:51:15.000Z thumbnail image

Stay in the know with updates to IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.